HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laia Alsina Selected Research

Aftercare (After-Treatment)

1/2018Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laia Alsina Research Topics

Disease

8Infections
01/2022 - 07/2011
4Inflammation (Inflammations)
01/2021 - 11/2010
2Atopic Dermatitis (Atopic Eczema)
01/2021 - 09/2015
2Lymphopenia (Lymphocytopenia)
01/2021 - 11/2012
2Neoplasms (Cancer)
01/2021 - 07/2018
2Herpes Simplex Encephalitis (Herpes Encephalitis)
11/2019 - 01/2018
2Autoimmune Diseases of the Nervous System
11/2019 - 01/2018
2Persistent Infection
07/2018 - 05/2013
2Reinfection
01/2018 - 01/2015
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 09/2015
2Sepsis (Septicemia)
02/2016 - 01/2013
2Virus Diseases (Viral Diseases)
09/2015 - 12/2010
2Pneumococcal Infections
09/2015 - 11/2010
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2012 - 07/2011
1Primary Immunodeficiency Diseases
04/2022
1COVID-19
01/2022
1Cytopenia
01/2022
1Central Nervous System Vasculitis
01/2022
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2022
1Congenital Disorders of Glycosylation
01/2022
1Asthma (Bronchial Asthma)
04/2021
1Cytokine Release Syndrome
01/2021
1Dermatitis
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1Measles
01/2021
1Mumps
01/2021
1Mycoses (Diseases, Fungus)
01/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Rubella (German Measles)
01/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Macrophage Activation Syndrome
01/2021
1Bacterial Meningitis
09/2020
1Dysgammaglobulinemia
01/2020
1Lung Diseases (Lung Disease)
01/2018
1Common Variable Immunodeficiency
01/2018
1Kabuki syndrome
01/2018
1Seizures (Absence Seizure)
01/2018
1Tuberculosis (Tuberculoses)
01/2018
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2018
1Obesity
01/2017
1Hypersensitivity (Allergy)
01/2017
1Critical Illness (Critically Ill)
02/2016
1Job Syndrome (Hyper-IgE Syndrome)
09/2015
1Candidiasis (Moniliasis)
09/2015
1Abscess
09/2015
1Tyrosine Kinase 2 Deficiency
09/2015
1Cerebrospinal Fluid Leak
01/2015
1Human Influenza (Influenza)
04/2013

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2022 - 01/2013
4Immunoglobulin E (IgE)IBA
01/2021 - 09/2012
3Immunoglobulins (Immunoglobulin)IBA
04/2022 - 01/2018
3VaccinesIBA
01/2021 - 07/2011
2Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2018
2Interleukin-12 (IL 12)IBA
01/2017 - 09/2015
2InterferonsIBA
04/2013 - 12/2010
1Glycoproteins (Glycoprotein)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1phosphomannomutaseIBA
01/2022
1Abatacept (Orencia)FDA Link
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1fludarabineIBA
01/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1AzolesIBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Chemokine CCL5IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Interleukin-27 (Interleukin 27)IBA
01/2021
1eculizumabFDA Link
09/2020
1Toll-Like Receptor 3IBA
11/2019
1BCG VaccineFDA Link
01/2018
1AntigensIBA
01/2018
1AntibodiesIBA
01/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018
1Adalimumab (Humira)FDA Link
01/2017
1Infliximab (Remicade)FDA Link
01/2017
1Glutamine (L-Glutamine)FDA Link
02/2016
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
02/2016
1Congenital disorder of glycosylation type 1AIBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
09/2015
1Interleukin-23 (Interleukin 23)IBA
09/2015
1Interleukin-10 (Interleukin 10)IBA
09/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
01/2015
1Phosphotransferases (Kinase)IBA
12/2014
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
05/2013
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
04/2013
1Polymyxin B (Aerosporin)FDA LinkGeneric
01/2013

Therapy/Procedure

4Therapeutics
01/2022 - 01/2013
1Splenectomy
01/2022
1Biological Therapy
04/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Retreatment
01/2020
1Transplantation
07/2018
1Aftercare (After-Treatment)
01/2018
1Mediterranean Diet
01/2017
1Parenteral Nutrition
02/2016
1Drug Therapy (Chemotherapy)
01/2015
1Immunomodulation
01/2013